openPR Logo
Press release

U.S Tapentadol Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Johnson & Johnson Services, Inc and Grünenthal Ltd, UK

11-26-2025 12:48 PM CET | Chemicals & Materials

Press release from: DataM Intelligence 4 Market Research LLP

Tapentadol Market - DataM Intelligence

Tapentadol Market - DataM Intelligence

Global Tapentadol Market is estimated to grow at a CAGR of 6.5% during the forecast period 2024-2031.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/tapentadol-market?sg

Key market players & competitive landscape (2025)

✅ The market remains dominated by original‐innovator firms and large generics: Grünenthal GmbH (original discoverer / marketer of branded Tapentadol), and generics producers such as Teva Pharmaceutical Industries Ltd. among others.

✅ According to one report, Grünenthal's branded formulations - immediate-release and extended-release - along with generics from multiple companies, together account for major market share globally (~30%+ for Grünenthal as of 2025).

✅ In markets like India, local firms including Sun Pharmaceutical Industries Ltd. are listed among leading manufacturers/players for Tapentadol in 2025.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/tapentadol-market?sg

Market growth drivers:

✅ Rising prevalence of chronic and acute pain conditions - aging populations and higher reported rates of chronic pain increase demand for effective analgesics. (Demographic & clinical demand).

✅ Clinical preference as an alternative analgesic - Tapentadol combines opioid μ-agonism and norepinephrine reuptake inhibition, making it a preferred option for certain moderate-to-severe pain regimens and post-surgical pain management in some markets. This supports adoption in hospitals and clinics.

✅ Patent expiries / generics & API production - patent cliffs and expanded generic/API manufacturing (especially in India and other emerging markets) are increasing supply, broadening access and lowering prices - a major volume driver.

✅ Expanding healthcare access in APAC & LATAM - improvements in healthcare infrastructure and reimbursement in emerging markets lift uptake. Several market reports flag APAC as the fastest-growing regional market.

✅ Regulatory & safety dynamics (two-edged) - increased scrutiny over opioid misuse and tighter prescription controls can limit growth in some countries; conversely, stronger regulatory frameworks that allow controlled use support predictable market expansion. Recent reports and news also point to localized abuse problems that can shape policy and supply chains.

Regional share & outlook:

➠ North America - largest region today. The U.S. is the dominant single-country market, driven by clinical adoption, a large elderly population, and established prescribing practices (industry reports commonly place North America as #1, often ~30-40% of global value in market breakdowns).

➠ Europe - #2 by revenue. Mature market with steady demand; growth steady but slower than APAC due to market maturity and regulatory constraints.

➠ Asia-Pacific - fastest growth. Higher CAGR expectations driven by expanding access, rising healthcare spend, and entry of generics/manufacturers (India, China). APAC is expected to narrow the gap as generic supply ramps.

Segments Covered in the Tapentadol Market:

By Product Type (100 mg, 75 mg, and 50 mg)

By Application (Musculoskeletal Pain and Diabetic peripheral neuropathy)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

Regional Analysis for Tapentadol Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=tapentadol-market?sg

Major Key Players: Johnson & Johnson Services, Inc and Grünenthal Ltd, UK

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Tapentadol market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Tapentadol Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Tapentadol market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Tapentadol Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription?sg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S Tapentadol Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Johnson & Johnson Services, Inc and Grünenthal Ltd, UK here

News-ID: 4289678 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

U.S Building Materials Market 2025: Industry Developments, Future Growth, Share & Industry Insights | CEMEX, Lafarge Holcim, Boral Limited, Buzzi Unicem SpA, Dyckerhoff AG
U.S Building Materials Market 2025: Industry Developments, Future Growth, Share …
Global Building Materials Market reached USD 1.3 trillion in 2022 and is expected to reach USD 1.7 trillion by 2031 growing with a CAGR of 3.9% during the forecast period 2024-2031. Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/building-materials-market?sg Major M&A / Corporate Moves & Strategy Shifts: ✅ 2025‐09‐22: CRH plc completed its acquisition of Eco Material Technologies (a US-based supplier of supplementary cementitious materials - SCMs, fly ash, pozzolans) for USD 2.1 billion.
Disease-modifying therapies market is expected to reach US$ 112.64 Billion by 2033 | Genentech USA Inc., Novartis AG, Teva Neuroscience Inc, GSK, AstraZeneca, AbbVie Inc, Amgen Inc
Disease-modifying therapies market is expected to reach US$ 112.64 Billion by 20 …
Global disease-modifying therapies market size was US$ 65.32 Billion in 2024 and is expected to reach US$ 112.64 Billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033 Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/disease-modifying-therapies-market?sg Major Deals & M&A: ✅ 2025‐04‐30: Novartis agreed to acquire Regulus Therapeutics for up to USD 1.7 billion, primarily to gain its lead investigational DMT candidate farabursen (for autosomal dominant polycystic kidney disease, ADPKD).
United States Epoxy Resins Market Projected to hit US$ 18.7 Billion by 2031 | Top 5 Companies are Nan Ya Plastics Corporation, Olin Corporation, and The Dow Chemicals Company.
United States Epoxy Resins Market Projected to hit US$ 18.7 Billion by 2031 | To …
Global Epoxy Resins Market reached US$ 12.1 Billion in 2024 and is expected to reach US$ 18.7 Billion by 2031, growing with a CAGR of 5.6% during the forecast period 2024-2031. Get a Free Sample PDF Of This Report: https://datamintelligence.com/download-sample/epoxy-resins-market?kb Key Players: E. I. Du Pont De Nemours and Company, Hexion Inc., Huntsman Corporation, Kukdo Chemicals Co. Ltd., Nan Ya Plastics Corporation, Olin Corporation, and The Dow Chemicals Company. Growth Forecast Projection: The Global Epoxy
United States Test and Measurement Equipment Market is to reach $11.31 billion by 2034, Test Equipment segment leads with 62.4% | Asia Pacific leads with 41.5% global market share .
United States Test and Measurement Equipment Market is to reach $11.31 billion b …
Leander, Texas- The U.S. test and measurement equipment market was valued at an estimated $8.47 billion in 2024 and is projected to reach approximately $11.31 billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 3.21% during that period. The market is driven by rapid technological advancements in electronics, telecommunications (including 5G), and Industry 4.0. Increased adoption of IoT, electric and autonomous vehicles, and renewable energy also necessitate sophisticated

All 5 Releases


More Releases for Tapentadol

Tapentadol Market to Witness Huge Growth by 2031 - Johnson & Johnson Services, I …
DataM Intelligence has published a new research report on "Tapentadol Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/tapentadol-market The
The Tapentadol Market to witness an innovative overhaul between 2017 - 2025
Tapentadol Market Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of
The next 10 years to see the Tapentadol Market making green strides
Tapentadol Market Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of
Tapentadol Market Grows With Changing Consumer Preferences & New Opportunities
Market: Overview Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of
Tapentadol Market High Growth Rate by 2025
Global Tapentadol Market: Snapshot The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide. Tapentadol is also used for the treatment of moderate to severe acute pain. The potency of this treatment lies somewhere between that of morphine and tramadol. Despite the lower occurrence of side effects, its analgesic efficacy is
Middle East Tapentadol Market Forecast to 2025
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and